RAP 0.00% 20.5¢ raptor resources limited

Ann: Update on US FDA De Novo Classification Request, page-316

  1. 275 Posts.
    lightbulb Created with Sketch. 52
    Emergency Use Authorisation isn't the best pathway because approval is only valid for duration of emergency and may not allow for expansions of product. De Novo submission is likely still the only viable pathway, however I know for a fact that FDA is prioritising devices applicable to covid.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.